Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Indian manufacturer of generic active pharmaceutical ingredients (APIs), Nectar Lifesciences, has received European cGMP (Current Good Manufacturing Practices) approval for its Cephalasporin Formulations manufacturing facility in the state of Himachal Pradesh.
Subscribe to our email newsletter
The facility, Unit-VI, has been granted approval for Cefotaxime sodium for injection, Ceftriaxone sodium for injection and Cefuroxime sodium for injection, indiainfoline.com reported.
Following the approval, the company is likely to enter into 27 European Union member states, EEU, South Africa and Middle East markets.
The approval was granted following an inspection of the facility by the Hungarian Authority – National Institute for Quality and Organizational Development in Healthcare and Medicines, National Institute of Pharmacy.